NCT05523999 Recognition of a Cardiac Arrest Within the EMS
| NCT ID | NCT05523999 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hôpital NOVO |
| Condition | Cardiac Arrest |
| Study Type | OBSERVATIONAL |
| Enrollment | 50 participants |
| Start Date | 2024-06-03 |
| Primary Completion | 2025-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50 participants in total. It began in 2024-06-03 with a primary completion date of 2025-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to evaluate the average time taken by the Medical Regulation Assistants (MRA) to detect a cardiac arrest during the call to the EMS as well as the factors influencing this delay. Its main objective is to evaluate the delay, in seconds, between the call being picked up and the recognition of a cardiac arrest by the medical regulation assistant at the EMS 95
Eligibility Criteria
Inclusion Criteria : \- Any call resulting in the detection of a cardiac arrest during ARM regulation: calls to 15 and calls transmitted by 18 Exclusion Criteria : * Traumatic context * Call involving cardiac arrest already identified as such by the caller or 18 * Call with criteria of proven death * The caller does not speak French, the linguistic elements noted are not usable.
Contact & Investigator
Dr Ariane Zoya-Gillet
PRINCIPAL INVESTIGATOR
Hôpital NOVO
Frequently Asked Questions
Who can join the NCT05523999 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cardiac Arrest. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05523999 currently recruiting?
Yes, NCT05523999 is actively recruiting participants. Contact the research team at maryline.delattre@ght-novo.fr for enrollment information.
Where is the NCT05523999 trial being conducted?
This trial is being conducted at Pontoise, France.
Who is sponsoring the NCT05523999 clinical trial?
NCT05523999 is sponsored by Hôpital NOVO. The principal investigator is Dr Ariane Zoya-Gillet at Hôpital NOVO. The trial plans to enroll 50 participants.